Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04796207 · ClinicalTrials.gov registry record · NA
The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04796207 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 38 participants.
The verdict
NCT04796207, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Determine if the daily docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA) supplement will reduce serum levels of biomarkers of sub-concussion injuries over a course of American football season among collegiate football athletes.
Interventions
- DIETARY_SUPPLEMENT Fish Oil (DPA+EPA 2:1 ratio) Capsules
- DIETARY_SUPPLEMENT High Oleic Safflower Oil Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04796207
The ClinicalTrials.gov registry entry for NCT04796207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fish Oil (DPA+EPA 2:1 ratio) Capsules is the first listed.
NCT04796207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04796207 about?
NCT04796207 is a clinical study titled "The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes". Determine if the daily docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA) supplement will reduce serum levels of biomarkers of sub-concussion injuries over a course of American football season among collegiate football athletes.
What is the current status of trial NCT04796207?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-05-28. Estimated completion is 2020-01-28.
What interventions are being tested in trial NCT04796207?
The interventions under investigation include: Fish Oil (DPA+EPA 2:1 ratio) Capsules (DIETARY_SUPPLEMENT), High Oleic Safflower Oil Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04796207?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.